Recombinant human PADI2 / PAD2 protein is a Human Full Length protein, in the 1 to 665 aa range, expressed in Baculovirus infected Sf9, with >=61% purity and suitable for SDS-PAGE, FuncS.
M L R E R T V R L Q Y G S R V E A V Y V L G T Y L W T D V Y S A A P A G A Q T F S L K H S E H V W V E V V R D G E A E E V A T N G K Q R W L L S P S T T L R V T M S Q A S T E A S S D K V T V N Y Y D E E G S I P I D Q A G L F L T A I E I S L D V D A D R D G V V E K N N P K K A S W T W G P E G Q G A I L L V N C D R E T P W L P K E D C R D E K V Y S K E D L K D M S Q M I L R T K G P D R L P A G Y E I V L Y I S M S D S D K V G V F Y V E N P F F G Q R Y I H I L G R R K L Y H V V K Y T G G S A E L L F F V E G L C F P D E G F S G L V S I H V S L L E Y M A Q D I P L T P I F T D T V I F R I A P W I M T P N I L P P V S V F V C C M K D N Y L F L K E V K N L V E K T N C E L K V C F Q Y L N R G D R W I Q D E I E F G Y I E A P H K G F P V V L D S P R D G N L K D F P V K E L L G P D F G Y V T R E P L F E S V T S L D S F G N L E V S P P V T V N G K T Y P L G R I L I G S S F P L S G G R R M T K V V R D F L K A Q Q V Q A P V E L Y S D W L T V G H V D E F M S F V P I P G T K K F L L L M A S T S A C Y K L F R E K Q K D G H G E A I M F K G L G G M S S K R I T I N K I L S N E S L V Q E N L Y F Q R C L D W N R D I L K K E L G L T E Q D I I D L P A L F K M D E D H R A R A F F P N M V N M I V L D K D L G I P K P F G P Q V E E E C C L E M H V R G L L E P L G L E C T F I D D I S A Y H K F L G E V H C G T N V R R K P F T F K W W H M V P
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application FuncS | Reactivity Reacts | Dilution info - | Notes - |
Catalyzes the deimination of arginine residues of proteins.
KIAA0994, PAD2, PDI2, PADI2, Protein-arginine deiminase type-2, PAD-H19, Peptidylarginine deiminase II, Protein-arginine deiminase type II
Recombinant human PADI2 / PAD2 protein is a Human Full Length protein, in the 1 to 665 aa range, expressed in Baculovirus infected Sf9, with >=61% purity and suitable for SDS-PAGE, FuncS.
pH: 8
Constituents: 20% Glycerol (glycerin, glycerine), 0.64% Sodium chloride, 0.64% Tris HCl, 0.05% (R*,R*)-1,4-Dimercaptobutan-2,3-diol, 0.02% Potassium chloride
Affinity purified.
Catalyzes the deimination of arginine residues of proteins.
Belongs to the protein arginine deiminase family.
This product is an active protein and may elicit a biological response in vivo, handle with caution.
PADI2 also known as PAD2 or PADdeux is a protein that performs post-translational modification by converting arginine residues into citrulline residues in proteins through a process known as citrullination. This protein has an approximate mass of 75 kDa. PADI2 is expressed in many tissues but shows higher levels in the brain skeletal muscle and mammary gland. Within these tissues PADI2 plays a role in regulating various physiological processes by altering protein function through citrullination.
PADI2 contributes significantly to the regulation of gene expression protein function and signal transduction. PADI2 does not exist as part of a larger protein complex yet it interacts with other proteins to regulate cellular processes. In particular it modifies histones which impacts chromatin structure and gene expression playing a role in cell differentiation and immune response modulation. Its activity can affect various cellular outcomes by regulating the function and interaction of different protein substrates.
PADI2 takes part in gene regulation and cell differentiation processes by modifying histones and impacting chromatin structure. It is integral in pathways related to inflammation and immune responses such as the NF-kB signaling pathway enhancing its biological role. PADI2 interacts with multiple proteins including histones and other signaling molecules reinforcing its critical role in these pathways.
PADI2 has been linked to rheumatoid arthritis and multiple sclerosis due to its role in immune modulation and inflammation. In rheumatoid arthritis aberrant citrullination by PADI2 contributes to the production of autoantibodies which are involved in the disease's pathogenesis. It also associates with abnormal neural processes in multiple sclerosis where citrullinated proteins potentially contribute to the demyelination process. In these conditions PADI2's function relates closely with other citrullinating proteins such as PADI4 highlighting the interconnectedness of these pathways in disease.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
4-20% SDS-PAGE analysis of ab196406 at 2.6 μg stained with Coomassie Blue (lane 1). Lane 2 is a protein marker.
Example of specific activity of ab196406
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com